APA (7th ed.) Citation

Diana Alexandra Echeverria Proano, Fengcai Zhu, Xiaodong Sun, Jesús Zoco, Jyoti Soni, Neeraj Parmar, & S. Omar Ali. (2024). Efficacy, reactogenicity, and safety of the adjuvanted recombinant zoster vaccine for the prevention of herpes zoster in Chinese adults ≥ 50 years: A randomized, placebo-controlled trial. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Diana Alexandra Echeverria Proano, Fengcai Zhu, Xiaodong Sun, Jesús Zoco, Jyoti Soni, Neeraj Parmar, and S. Omar Ali. Efficacy, Reactogenicity, and Safety of the Adjuvanted Recombinant Zoster Vaccine for the Prevention of Herpes Zoster in Chinese Adults ≥ 50 Years: A Randomized, Placebo-controlled Trial. Taylor & Francis Group, 2024.

MLA (9th ed.) Citation

Diana Alexandra Echeverria Proano, et al. Efficacy, Reactogenicity, and Safety of the Adjuvanted Recombinant Zoster Vaccine for the Prevention of Herpes Zoster in Chinese Adults ≥ 50 Years: A Randomized, Placebo-controlled Trial. Taylor & Francis Group, 2024.